Research in mice lends credence to hospitals’ aggressive tactics to prevent and respond to deep-vein thrombosis. A commonly used medication that prevents blood clots from forming may also prevent existing clots from damaging delicate vein walls — and may accelerate healing in a clot-damaged area of vein wall. The findings, made in laboratory mice, add more evidence to support the aggressive anticlot efforts now under way at American hospitals and nursing homes.